8:30 am Check-In & Light Breakfast
9:30 am Chair’s Opening Remarks
Identifying the Opportunities for New Bioactive Ingredients
9:45 am Approaches to Explore Synergies Among Milk Bioactives for Infant Immune Health
Synopsis
- Need for understanding human milk and synergies
- Intricacies of the Infant Immune System
- Strategies to dissect synergistic effects of milk bioactives on infant immune health
10:15 am Demonstrating the Real-World Evidence of Innovative Infant Formulas to Guide Commercialization Strategy
Synopsis
- Exploring case studies incorporating novel ingredients in infant formulas
- Reflecting on consumer adoption trends to inform the next generation of innovation
- Combining scientific and regulatory excellence to diversify infant formulas and stabilize supply chains
10:45 am Innovations & Trends in Infant Formula & Nutrition Clinical Trials: Case Studies
Synopsis
- Optimizing accuracy & precision in anthropometric data capture
- Maximizing compliance with eObsRO diaries and anthropometrics
- AE and SAE rates in fully decentralized clinical trials
- Diversification of recruitment via digital approaches
- Strategies for caregiver engagement and participant retention
- Recommendations for longitudinal use of cognitive and developmental assessments
11:00 am Morning Break & Speed Networking
Synopsis
Our famous speed networking is the ideal opportunity to get face-to-face time with many of the brightest minds working in infant formula development and regulatory approval and introduce yourself to the attendees you would like to have more in-depth conversations with. Benchmark against industry leaders and establish meaningful relationships to pursue for the rest of the conference and beyond.
Advancing from Discovery to Preclinical Development with Regulatory Viability in Mind
12:00 pm ‘Innovation by Compositional Analyses’: Novel Communication Opportunities by Addressing Bioactive Ingredient Composition & Preclinical Functionality
Synopsis
- Dairy ingredient analytics can drive innovations, an example of bioactive proteins in MFGM-enriched whey
- The complex composition of galactooligosaccharides and its functionality
- Detailed ingredient analyses and challenges with registration
12:30 pm Improving the Selection & Usage of Animal Models to Generate High Quality Data for Dossier Compilation
Synopsis
- Evaluating the use of piglets given consumer expectations and labeling limitations
- Addressing the growing ethical pushback against animal testing
- Harmonizing validated cell-based assays that are fit for purpose to ensure standardized results
VIRTUAL
1:00 pm Networking Lunch
2:00 pm Human Milk Probiotic: An Opportunity to Support Premature Infants by Microbiota Modulation to Access Specialized Markets
Synopsis
- Reviewing the main benefits of probiotic bacteria in human milk
- Presenting clinical data that demonstrated the possible mechanisms involved in infection protection and gut health
- Benefits of Human Milk Probiotic in premature: modulation of microbiota and description of health benefits for premature infants
2:30 pm Production of Human Milk Fat Analogue by Fermentation of Microalgae
Synopsis
- Microbial fermentation technology leveraging microalgae to produce triacylglycerols (TAGs) with a composition that closely mimics human milk fat, addressing a critical gap in infant nutrition
- Engineered microalgae to achieve >70% sn-2 palmitate in TAGs such as OPO, supporting improved fat digestion, calcium absorption, and replication of the functional and physiological benefits of human milk fat
- Demonstrated successful scale-up to 15,000 L fermentation, with oil extraction and refining compatible with standard industrial processes, enabling near-term commercial readiness
3:00 pm Sharing Preclinical Updates to Improve the Bioavailability of Bioactive Ingredients
Synopsis
- Developing and producing lipid delivery systems of arachidonic and docosahexaenoic acids designed to improve the bioavailability of these two bioactive fatty acids
- Generating high-quality preclinical data to illustrate this improved bioavailability
- Sharing a snapshot of early clinical data